Karen B. Young

A Single Site (Ser16) Phosphorylation in Phospholamban Is Sufficient in Mediating Its Maximal Cardiac Responses to β-Agonists*

E. Kranias, G. Chu, W. Luo, 2000, The Journal of Biological Chemistry.

Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility.

J. Qian, E. Kranias, G. Chu, 2004, Journal of molecular and cellular cardiology.

Genetic Alterations and Modeling of Cardiovascular Physiology

E. Kranias, A. Schmidt, V. Kadambi, 2001 .

Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.

Andrew N. Carr, J. Seidman, G. Dorn, 2003, The Journal of clinical investigation.

Overexpression of phospholamban in slow‐twitch skeletal muscle is associated with depressed contractile function and muscle remodeling

I. Grupp, J. Robbins, J. Gulick, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.

Andrew N. Carr, S. Schwartz, J. Molkentin, 2002, Cardiovascular research.

Structure and expression of the mouse cardiac calsequestrin gene

E. Kranias, Yoji Sato, G. Chu, 2001, Basic Research in Cardiology.